KaydedilenlerDerginizi ekleyin

Dergiler / Üroonkoloji Bülteni / 2018 / Cilt: 17 - Sayı: 3

A Rare Tumor: Small Cell Prostate Carcinoma Case Report

Mehmet Erhan AYDIN
Deniz BOLAT
FUNDA TAŞLI
TANSU DEĞİRMENCİ
BÜLENT GÜNLÜSOY
Sayfa
113–116
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Herein, we present a case of previously diagnosed prostate adenocarcinoma that transformed to prostate small cell carcinoma, together with a discussion of the current literature.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Prostate small cell carcinoma is a rare and aggressive tumor.
📊
Temel Bulgular & Veri:They can be distinguished from classic prostate adenocarcinoma by features such as lack of prostate-specific antigen secretion, failure to respond to androgen suppression therapy, osteolytic bone lesions, and visceral metastasis.
💡
Sonuç & Katkı:Herein, we present a case of previously diagnosed prostate adenocarcinoma that transformed to prostate small cell carcinoma, together with a discussion of the current literature.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Prostate small cell carcinoma is a rare and aggressive tumor. They can be distinguished from classic prostate adenocarcinoma by features such as lack of prostate-specific antigen secretion, failure to respond to androgen suppression therapy, osteolytic bone lesions, and visceral metastasis. Herein, we present a case of previously diagnosed prostate adenocarcinoma that transformed to prostate small cell carcinoma, together with a discussion of the current literature.

🔖

Bu Makaleye Atıf Yap

AYDIN, M. E., BOLAT, D., TAŞLI, F., DEĞİRMENCİ, T., GÜNLÜSOY, B. (2018). A Rare Tumor: Small Cell Prostate Carcinoma Case Report. Üroonkoloji Bülteni, Cilt: 17 - Sayı: 3, 113–116. https://ajindex.com/articles/334897

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136: 359-386.
  2. Helpap B, Köllermann J, Oehler U. Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives. Urol Int 1999;62:133-138.
  3. Demirtaş A, Sahin N, Oztürk F, et al. Small cell prostate carcinoma: a case report and review of the literature. Case Rep Urol 2013;2013:387931. Wenk RE, Bhagavan BS, Levy R, et al. Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia. Cancer 1977;40:773-778. López Cubillana P, Martínez Barba E, Prieto A, et al. Oat-cell carcinoma of the prostate. Diagnosis, prognosis and therapeutic implications. Urol Int 2001;67:209-212.
  4. Wang HT, Yao YH, Li BG, et al. Neuroendocrine Prostate Cancer (NEPC) progressing from conventional prostatic adenocarcinoma: factors associated with time to development of NEPC and survival from NEPC diagnosis-a systematic review and pooled analysis. J Clin Oncol 2014;32:3383-3390.
  5. Albisinni S, De Nunzio C, Tubaro A. Pure small cell carcinoma of the prostate: A rare tumor. Indian J Urol 2012;28:89-91.
  6. Durmaz M, Kılınç F, Buldu İ, et al. Small cell carcinoma of the prostate in differential diagnosis - A case report. Gaziantep Med J 2016;22:160-163
  7. Wang W, Epstein JI. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases. Am J Surg Pathol 2008;32:65-71. Abrahamsson PA. Neuroendocrine differentiation in prostatic carcinoma. Prostate 1999;39:135-148.
  8. Capizzello A, Peponi E, Simou N, et al. Pure small cell carcinoma of the prostate: a case report and literature review. Case Rep Oncol 2011;4:88-95.
  9. Sella A, Konichezky M, Flex D, et al. Low PSA metastatic androgen- independent prostate cancer. Eur Urol 2000;38:250-254. Têtu B, Ro JY, Ayala AG, et al. Small cell carcinoma of prostate associated with myasthenic (Eaton-Lambert) syndrome. Urology 1989;33:148-152.
  10. Papandreou CN, Daliani DD, Thall PF, et al. Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol 2002;20:3072-3080.
  11. Rubenstein JH, Katin MJ, Mangano MM, et al. Small cell anaplastic carcinoma of the prostate: seven new cases, review of the literature, and discussion of a therapeutic strategy. Am J Clin Oncol 1997;20:376-380.
  12. Stein ME, Bernstein Z, Abacioglu U, et al.